Tara Bancroft
Stock Analyst at TD Cowen
(2.56)
# 2,032
Out of 4,829 analysts
8
Total ratings
50%
Success rate
19.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $34.99 | +42.90% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $45.27 | +43.58% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $7.39 | +48.95% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.28 | +681.25% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $42.41 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.60 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $34.99
Upside: +42.90%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $45.27
Upside: +43.58%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $7.39
Upside: +48.95%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $42.41
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.60
Upside: -